cdmo.directory
← Compare landing

Galenvs Sciences vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/galenvs-sciences/sinopep

CategoryGalenvs SciencesSinopep-Allsino Biopharmaceutical Co., Ltd.
Listed sitecdmocdmo
SummaryGalenvs makes modified, specialty oligonucleotides for drug and gene-therapy programs, from proof of concept to pilot scale, under an ISO 9001:2015 certified quality system.GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Services
  • Oligonucleotide Manufacturing
  • Process Development
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Oligonucleotide
  • Peptide
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Montréal, Québec, Canada
Data not yet provided.
Certifications
  • ISO · Identifier: ISO 9001:2015
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.